Inflazome
Latest round
- Series B
Last raised
- Nov 2018
Total raised
- $62M
Investors
- 4
About Inflazome
Inflazome Ltd.Founded in 2016 and headquartered in Dublin, Ireland, Inflazome Ltd. focuses on creating breakthrough treatments for inflammatory conditions. The company has successfully completed a TRADE SALE in September 2020, where it was acquired by F. Hoffmann-La Roche Ltd for EUR 380 million, with potential milestone payments.Inflazome Ltd. specializes in therapeutic solutions that address inflammatory diseases, leveraging advanced scientific research to develop novel compounds. Their product pipeline includes innovative treatments that are designed to modulate immune responses, with a focus on conditions such as cardiovascular diseases, neurodegenerative disorders, and metabolic syndromes.In the most recent year of 2019, Inflazome Ltd.Inflazome Ltd. aims to leverage its recent acquisition by F. Hoffmann-La Roche Ltd to expedite the development and commercialization of its therapeutic products. The focus is on expanding its product portfolio with new treatments for inflammatory diseases, although specific upcoming product launches have not been disclosed. The company also plans to enhance its presence in North America and Europe, utilizing the EUR 380 million received from the TRADE SALE to support research and development initiatives and to strengthen its market position.
Who invested in Inflazome
4 investors across 2 rounds
See all investors in Inflazome
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Inflazome
Who invested in Inflazome?
Inflazome has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inflazome raised?
Inflazome has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Inflazome last raise money?
Inflazome's most recent round on record is a Series B, in Nov 2018.
What does Inflazome do?
Inflazome is a pharmaceuticals company.
Where is Inflazome headquartered?
Inflazome is headquartered in Dublin, Ireland.
Which VCs invest in companies like Inflazome?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Inflazome's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Inflazome? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.